IRMD IRadimed Corporation
Healthcare$92.94+0.91%ClosedMarket Cap: $1.19B
As of 2026-05-26
Valuation
P/E (TTM)
53.11
PEG
3.15
P/B
11.95
P/S
13.64
EV/EBITDA
36.70
DCF Value
$43.35
FCF Yield
2.0%
Div Yield
1.3%
Margins & Returns
Gross Margin
76.8%
Operating Margin
32.4%
Net Margin
27.4%
ROE
24.5%
ROA
20.6%
ROIC
21.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $22.0M | 76.5% | $7.2M | $5.8M | $— | $0.20 |
| Q4 null | $22.7M | 75.1% | $7.1M | $6.4M | $— | $0.67 |
| FY null | $83.8M | 76.7% | $26.1M | $22.5M | $— | $1.18 |
| Q3 null | $21.2M | 77.8% | $6.8M | $5.6M | $— | $0.17 |
| Q2 null | $20.4M | 78.2% | $6.8M | $5.8M | $— | $0.17 |
| Q1 null | $19.5M | 76.1% | $5.4M | $4.7M | $— | $0.17 |
| Q4 null | $19.4M | 76.1% | $5.8M | $5.1M | $— | $0.15 |
| FY null | $73.2M | 76.9% | $22.0M | $19.2M | $— | $0.45 |
| Q3 null | $18.3M | 77.4% | $5.8M | $5.0M | $— | $0.15 |
| Q2 null | $17.9M | 78.1% | $5.6M | $4.9M | $— | $0.15 |
| Q1 null | $17.6M | 76.1% | $4.7M | $4.1M | $— | — |
| Q4 2023 | $17.5M | 76.9% | $5.2M | $4.5M | $0.36 | $0.63 |